Tour the CRISPR Vision Program Lab at the University of Wisconsin- Madison WID!
IEEE Madison’s November 7th 3 pm tour is at the Wisconsin Institute for Discovery’s Saha Lab where they use CRISPR technology for addressing inherited retinal disorders. We’ll tour the lab, see a CRISPR machine and see how the output is used.
Welcome to the CRISPR Vision Program at the University of Wisconsin- Madison! UW – Madison is a part of the Somatic Cell Genome Editing (SCGE) Consortium funded by the National Institutes of Health (NIH). We're innovating non-viral gene editing therapies for inherited retinal disorders. Our work aims to bring the groundbreaking potential of CRISPR technology to those affected by these diseases.
The labs focus lies in overcoming the limitations of existing viral delivery systems and introducing novel, non-viral treatments for inherited eye diseases, particularly those affecting the retinal pigment epithelium.
As a part of the SCGE Consortium, the lab is working in a community dedicated to developing safe and effective gene editing methods to treat genetic diseases in somatic cells.
Related links for your review
https://crisprvision.wid.wisc.edu
https://sahalab.bme.wisc.edu/#home
https://www.waisman.wisc.edu/staff/saha-krishanu/
Date and Time
Location
Hosts
Registration
- Start time: 07 Nov 2024 03:00 PM
- End time: 07 Dec 2024 04:30 PM
- All times are (UTC-06:00) Central Time (US & Canada)
-
Add Event to Calendar
- We will meet on the first floor of WID near the double elevators.
- 330 North Orchard Street
- Madison, Wisconsin
- United States 53715
- Building: Wisconsin Institute for Discovery (WID)
- Room Number: Room 4164
- Click here for Map
- Starts 15 October 2024 12:00 AM
- Ends 07 November 2024 12:00 AM
- All times are (UTC-06:00) Central Time (US & Canada)
- No Admission Charge
Speakers
Kris Saha of University of WI Madison
Tour of Saha Lab
Krishanu Saha PhD
Is an Associate Professor in Biomedical Engineering and works with cellular reprogramming to allow for the generation of a self-renewing and patient-specific cell source for drug discovery, cell therapies, and regenerative medicine through the generation of human induced pluripotent stem cells (hiPSCs ).
Ross Schwartz
Is the Laboratory Manager for Saha Lab, part of the Administration team for U19 CRISPR Vision, and a Program Coordinator for the CMaT NSF program. He graduated with a Master's Degree in Evolution, Ecology and Organismal Biology from the Ohio State University.